Form 4: Fulgent Genetics CEO Sells Shares to Cover Tax Obligations
Statement of Changes in Beneficial Ownership
Fulgent Genetics' CEO, Ming Hsieh, sold shares to satisfy tax obligations related to vested restricted stock units.
Summary
- Fulgent Genetics' Chief Executive Officer, Ming Hsieh, had 2,324 shares withheld to cover tax obligations.
- These obligations arose from the vesting of restricted stock units that were previously granted on February 23, 2023.
- The shares were sold at a price of $16.46 each.
- Following the transaction, Mr. Hsieh directly owns 699,915 shares of common stock.
- He also has indirect ownership through various trusts and accounts, including the Dynasty Trust and The Ming Hsieh Trust.
Sentiment
Score: 5
Explanation: The document is neutral. It reports a standard transaction with no positive or negative implications for the company's future.
Positives
- The transaction is a standard procedure to cover tax liabilities arising from equity compensation.
- Mr. Hsieh retains a significant direct and indirect ownership stake in the company, indicating continued alignment with shareholder interests.
Negatives
- The sale, although for tax purposes, reduces Mr. Hsieh's direct ownership stake in the company.
Risks
- There are no specific risks outlined in the document, other than standard risks associated with stock ownership and market fluctuations.
Future Outlook
The document does not contain any explicit forward-looking statements.
Industry Context
This announcement is a standard SEC Form 4 filing, common for publicly traded companies when insiders' ownership stakes change. It reflects routine transactions related to executive compensation and tax obligations.
Comparison to Industry Standards
- This type of transaction is standard practice across the industry.
- Companies often withhold shares to cover employee tax liabilities upon vesting of restricted stock units.
- Comparable companies like Invitae (NVTA) and Natera (NTRA) would have similar filings when their executives have shares withheld for tax purposes related to equity compensation.
Stakeholder Impact
- The transaction has a minimal impact on shareholders, as it is a routine event related to executive compensation.
Key Dates
| Date | Description |
|---|---|
| 2023-02-23 | Date of the original grant of restricted stock units to the reporting person. |
| 2023-02-27 | Date the original grant was reported on Form 4 filed with the U.S. Securities and Exchange Commission. |
| 2025-02-23 | Date of the transaction where shares were withheld for tax purposes. |
| 2025-02-25 | Signature date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.